Why General Catalyst Is Betting $450M on Function Health’s Preventive Care Push
Operate Well being raised $450 million in progress financing from Basic Catalyst’s Buyer Worth Fund, simply eight months after its ...
Tag: 450M
Ipsen’s $450M Deal Brings Drug That Could Make a Standard Blood Cancer Therapy Better
Ipsen is buying Kartos Therapeutics to get navtemadlin, which has reached Part 3 testing within the blood most cancers myelofibrosis. ...
BridgeBio Oncology to Go Public in SPAC Deal Bringing $450M+ for Trio of Cancer Drugs
BridgeBio Oncology Therapeutics, a company working to advance the field of therapies addressing a validated but elusive group of cancer ...
Discover the latest in health and fitness with Your Health 247. Get expert advice, workout routines, healthy recipes, and mental wellness tips to lead a healthier, happier life. Stay informed and empowered with us!